Wanek, T.; Raabe, M.; Alam, M.N.A.; Filip, T.; Stanek, J.; Loebsch, M.; Laube, C.; Mairinger, S.; Weil, T.; Kuntner, C.
Functionalization of 68Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities. Pharmaceuticals 2024, 17, 514.
https://doi.org/10.3390/ph17040514
AMA Style
Wanek T, Raabe M, Alam MNA, Filip T, Stanek J, Loebsch M, Laube C, Mairinger S, Weil T, Kuntner C.
Functionalization of 68Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities. Pharmaceuticals. 2024; 17(4):514.
https://doi.org/10.3390/ph17040514
Chicago/Turabian Style
Wanek, Thomas, Marco Raabe, Md Noor A Alam, Thomas Filip, Johann Stanek, Mathilde Loebsch, Christian Laube, Severin Mairinger, Tanja Weil, and Claudia Kuntner.
2024. "Functionalization of 68Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities" Pharmaceuticals 17, no. 4: 514.
https://doi.org/10.3390/ph17040514
APA Style
Wanek, T., Raabe, M., Alam, M. N. A., Filip, T., Stanek, J., Loebsch, M., Laube, C., Mairinger, S., Weil, T., & Kuntner, C.
(2024). Functionalization of 68Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities. Pharmaceuticals, 17(4), 514.
https://doi.org/10.3390/ph17040514
